Biogen Idec was pleased to announce last week that the FDA has approved an update to the prescription labeling of the drug Tysabri (natalizumab), their monthly IV monoclonal antibody medication for MS. The prescription label now includes information regarding the increased risk of developing pr...


Test Your MS Knowledge
Even More Famous Faces with Multiple Sclerosis!
10 Foods That Fight Inflammation
Unusual Multiple Sclerosis Symptoms
I'm hopeing to test a new M.S. treatment it's not a cure but does have it's benifits!
Do tell us what it is!!!